Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             67 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A great Russian scientist has died
12 11 p. 1499-1503
artikel
2 A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma Blanke, C.D.

12 11 p. 1575-1580
artikel
3 A phase II study of irinotecan with 5-fluorouracil and leucovorinin patients with previously untreated gastric adenocarcinoma C. D. Blanke
2001
12 11 p. 1575-1580
6 p.
artikel
4 A phase I study of sequential intravenous topotecan and etoposide in lung cancer patients Huisman, C.

12 11 p. 1567-1573
artikel
5 A phase I study of sequential intravenous topotecan and etoposidein lung cancer patients C. Huisman
2001
12 11 p. 1567-1573
7 p.
artikel
6 Appointment Kerr, David

12 11 p. 1499-1503
artikel
7 B. D. Cheson (ed), Monoclonal Antibody Therapy of Hematologic Malignancies A. Engert
2001
12 11 p. 1504-1504
1 p.
artikel
8 Book review Aebi, S.

12 11 p. 1654
artikel
9 Book review Engert, A.

12 11 p. 1504
artikel
10 Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation Picci, P.

12 11 p. 1601-1604
artikel
11 Computed tomography of pulmonary metastases from osteosarcoma:The less poor technique. A study of 51 patients withhistological correlation P. Picci
2001
12 11 p. 1601-1604
4 p.
artikel
12 Contents of the next issue
12 11 p. iv
artikel
13 Copyright
12 11 p. ii
artikel
14 Dietary glycemic index and glycemic load, and breast cancer risk: A case-control study Augustin, L.S.A.

12 11 p. 1533-1538
artikel
15 Dietary glycemic index and glycemic load, and breast cancer risk:A case-control study L. S. A. Augustin
2001
12 11 p. 1533-1538
6 p.
artikel
16 Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer Fogli, S.

12 11 p. 1553-1559
artikel
17 Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer S. Fogli
2001
12 11 p. 1553-1559
7 p.
artikel
18 Editorial Board
12 11 p. iii
artikel
19 Evaluation and appraisal of randomized controlled trials in myeloma B. Djulbegovic
2001
12 11 p. 1611-1617
7 p.
artikel
20 Evaluation and appraisal of randomized controlled trials in myeloma* * Presented at the 36th American Society of Clinical Oncology Meeting, New Orleans, May 20–23, 2001 Djulbegovic, B.

12 11 p. 1611-1617
artikel
21 Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable? Carlini, P.

12 11 p. 1539-1543
artikel
22 Formestane, a steroidal aromatase inhibitor after failure ofnon-steroidal aromatase inhibitors (anastrozole and letrozole): Is aclinical benefit still achievable? P. Carlini
2001
12 11 p. 1539-1543
5 p.
artikel
23 Gemcitabine-induced systemic capillary leak syndrome De Pas, T.

12 11 p. 1651-1652
artikel
24 Gemcitabine-induced systemic capillary leak syndrome T. De Pas
2001
12 11 p. 1651-1652
2 p.
artikel
25 Glycemic index, hyperinsulinemia, and breast cancer risk Key, T.J.

12 11 p. 1507-1509
artikel
26 Glycemic index, hyperinsulinemia, and breast cancer risk T. J. Key
2001
12 11 p. 1507-1509
3 p.
artikel
27 Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule Schüll, B.

12 11 p. 1653-1654
artikel
28 Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule B. Schüll
2001
12 11 p. 1653-1654
2 p.
artikel
29 In this issue
12 11 p. iv
artikel
30 J. A. Ledermann, W. J. Hoskins, S. B. Kaye,I. B. Vergote (eds), Clinical Management of Ovarian Cancer S. Aebi
2001
12 11 p. 1654-1654
1 p.
artikel
31 Localised disease in cancer of unknown primary (CUP): The value of positron emission tomography (PET) for individual therapeutic management Rades, D.

12 11 p. 1605-1609
artikel
32 Localised disease in cancer of unknown primary (CUP): The value ofpositron emission tomography (PET) for individualtherapeutic management D. Rades
2001
12 11 p. 1605-1609
5 p.
artikel
33 Micronutrients and ovarian cancer: A case-control study in Italy Bidoli, E.

12 11 p. 1589-1593
artikel
34 Micronutrients and ovarian cancer: A case-control study in Italy E. Bidoli
2001
12 11 p. 1589-1593
5 p.
artikel
35 More on the benefits of smoking
12 11 p. 1499-1503
artikel
36 N-(phosphonacetyl)-l-aspartate and calcium leucovorin modulation offluorouracil administered by constant rate and circadian pattern ofinfusion over 72 hours in metastatic gastrointestinaladenocarcinoma J. L. Grem
2001
12 11 p. 1581-1587
7 p.
artikel
37 N-(phosphonacetyl)-l-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma* * The US Government’s right to retain a non-exclusive, royalty-free licence in and to any copyright is acknowledged Grem, J.L.

12 11 p. 1581-1587
artikel
38 Once again: Natural is not benign
12 11 p. 1499-1503
artikel
39 Once again: Natural is not benign • The sorcerers apprentice • Sleep: A need that one should not neglect • Swiss revolution? • More on the benefits of smoking • A great Russian scientist has died • There is no clean war • Appointment • Perhaps not everyone knows that... 2001
12 11 p. 1499-1503
5 p.
artikel
40 Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors Marty, M.

12 11 p. 1643-1649
artikel
41 Oral vinorelbine pharmacokinetics and absolute bioavailabilitystudy in patients with solid tumors M. Marty
2001
12 11 p. 1643-1649
7 p.
artikel
42 Perhaps not everyone knows that…
12 11 p. 1499-1503
artikel
43 Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks M. L. Rothenberg
2001
12 11 p. 1631-1641
11 p.
artikel
44 Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks* * Preliminary findings of this study were presented at the 10th NC1-EORTC Symposium on New Drugs in Cancer Therapy, 1998 Rothenberg, M.L.

12 11 p. 1631-1641
artikel
45 Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents Sekine, I.

12 11 p. 1515-1525
artikel
46 Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents I. Sekine
2001
12 11 p. 1515-1525
11 p.
artikel
47 Pre-operative endocrine therapy for postmenopausal women: When and why? Tondini, C.

12 11 p. 1505-1506
artikel
48 Pre-operative endocrine therapy for postmenopausal women: When and why? C. Tondini
2001
12 11 p. 1505-1506
2 p.
artikel
49 Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study Eiermann, W.

12 11 p. 1527-1532
artikel
50 Preoperative treatment of postmenopausal breast cancer patientswith letrozole: A randomized double-blind multicenter study W. Eiermann
2001
12 11 p. 1527-1532
6 p.
artikel
51 Result of two randomized trials comparing nolatrexed (ThymitaqTM) versus methotrexate in patients with recurrent head and neck cancer X. Pivot
2001
12 11 p. 1595-1599
5 p.
artikel
52 Result of two randomized trials comparing nolatrexed (Thymitaq™) versus methotrexate in patients with recurrent head and neck cancer Pivot, X.

12 11 p. 1595-1599
artikel
53 Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study Paulussen, M.

12 11 p. 1619-1630
artikel
54 Second malignancies after Ewing tumor treatment in 690 patientsfrom a cooperative German/Austrian/Dutch study M. Paulussen
2001
12 11 p. 1619-1630
12 p.
artikel
55 Sleep: A need that one should not neglect
12 11 p. 1499-1503
artikel
56 Staging of breast cancer. Is the evidence so evident? Tassinari, D.

12 11 p. 1653
artikel
57 Staging of breast cancer. Is the evidence so evident? D. Tassinari
2001
12 11 p. 1653-1653
1 p.
artikel
58 Swiss revolution?
12 11 p. 1499-1503
artikel
59 Table of Contents
12 11 p. i-ii
artikel
60 Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer Kao, A.

12 11 p. 1561-1566
artikel
61 Technetium-99m methoxyisobutylisonitrile chest imaging forsmall-cell lung cancer A. Kao
2001
12 11 p. 1561-1566
6 p.
artikel
62 There is no ‘clean war’
12 11 p. 1499-1503
artikel
63 The sorcerer’s apprentice
12 11 p. 1499-1503
artikel
64 Time to consider HPV testing in cervical screening Cuzick, J.

12 11 p. 1511-1514
artikel
65 Time to consider HPV testing in cervical screening J. Cuzick
2001
12 11 p. 1511-1514
4 p.
artikel
66 Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer Fountzilas, G.

12 11 p. 1545-1551
artikel
67 Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer G. Fountzilas
2001
12 11 p. 1545-1551
7 p.
artikel
                             67 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland